BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kirtipal N, Bharadwaj S, Kang SG. From SARS to SARS-CoV-2, insights on structure, pathogenicity and immunity aspects of pandemic human coronaviruses. Infect Genet Evol 2020;85:104502. [PMID: 32798769 DOI: 10.1016/j.meegid.2020.104502] [Cited by in Crossref: 71] [Cited by in F6Publishing: 52] [Article Influence: 23.7] [Reference Citation Analysis]
Number Citing Articles
1 Shi K, Yi Z, Han Y, Chen J, Hu Y, Cheng Y, Liu S, Wang W, Song J. PAM-free cascaded strand displacement coupled with CRISPR-Cas12a for amplified electrochemical detection of SARS-CoV-2 RNA. Anal Biochem 2023;664:115046. [PMID: 36641031 DOI: 10.1016/j.ab.2023.115046] [Reference Citation Analysis]
2 Naidoo DB, Chuturgoon AA. The Potential of Nanobodies for COVID-19 Diagnostics and Therapeutics. Mol Diagn Ther 2023;:1-34. [PMID: 36656511 DOI: 10.1007/s40291-022-00634-x] [Reference Citation Analysis]
3 Kovalenko A, Ryabchevskaya E, Evtushenko E, Nikitin N, Karpova O. Recombinant Protein Vaccines against Human Betacoronaviruses: Strategies, Approaches and Progress. Int J Mol Sci 2023;24. [PMID: 36675218 DOI: 10.3390/ijms24021701] [Reference Citation Analysis]
4 Szczesniak I, Baliga-Gil A, Jarmolowicz A, Soszynska-Jozwiak M, Kierzek E. Structural and Functional RNA Motifs of SARS-CoV-2 and Influenza A Virus as a Target of Viral Inhibitors. Int J Mol Sci 2023;24. [PMID: 36674746 DOI: 10.3390/ijms24021232] [Reference Citation Analysis]
5 López Y, Muñoz-Leal S, Martínez C, Guzmán C, Calderón A, Martínez J, Galeano K, Muñoz M, Ramírez JD, Faccini-Martínez ÁA, Mattar S. Molecular evidence of Borrelia spp. in bats from Córdoba Department, northwest Colombia. Parasit Vectors 2023;16:5. [PMID: 36604762 DOI: 10.1186/s13071-022-05614-y] [Reference Citation Analysis]
6 Ye J, Li J, Zhao P. The Silkworm Carboxypeptidase Inhibitor Prevents Gastric Cancer Cells' Proliferation through the EGF/EGFR Signaling Pathway. Int J Mol Sci 2023;24. [PMID: 36674593 DOI: 10.3390/ijms24021078] [Reference Citation Analysis]
7 Al-eitan L, Sendyani S, Alnimri M. Applications of the One Health concept: Current Status in the Middle East. Journal of Biosafety and Biosecurity 2023. [DOI: 10.1016/j.jobb.2023.01.001] [Reference Citation Analysis]
8 Fitriana F, Herawati MH, Nugroho FS, Syachroni S. Variation of Covid-19 examination results between PCR reagent kits. THE 5TH INTERNATIONAL CONFERENCE ON MATHEMATICS AND SCIENCE EDUCATION (ICoMSE) 2021: Science and Mathematics Education Research: Current Challenges and Opportunities 2023. [DOI: 10.1063/5.0113006] [Reference Citation Analysis]
9 Grote K, Kreutz J, Schaefer A, Markus B, Schieffer B. The Renin Angiotensin System at the Time of COVID-19. The Renin Angiotensin System in Cardiovascular Disease 2023. [DOI: 10.1007/978-3-031-14952-8_9] [Reference Citation Analysis]
10 Abulsoud AI, El-Husseiny HM, El-Husseiny AA, El-Mahdy HA, Ismail A, Elkhawaga SY, Khidr EG, Fathi D, Mady EA, Najda A, Algahtani M, Theyab A, Alsharif KF, Albrakati A, Bayram R, Abdel-Daim MM, Doghish AS. Mutations in SARS-CoV-2: Insights on structure, variants, vaccines, and biomedical interventions. Biomed Pharmacother 2023;157:113977. [PMID: 36370519 DOI: 10.1016/j.biopha.2022.113977] [Reference Citation Analysis]
11 Kim JA, Kim SH, Seo JS, Noh H, Jeong H, Kim J, Jeon D, Kim JJ, On D, Yoon S, Lee SG, Lee YW, Jang HJ, Park IH, Oh J, Seok SH, Lee YJ, Hong SM, An SH, Bae JY, Choi JA, Kim SY, Kim YB, Hwang JY, Lee HJ, Kim HB, Jeong DG, Song D, Song M, Park MS, Choi KS, Park JW, Yun JW, Shin JS, Lee HY, Seo JY, Nam KT, Gee HY, Seong JK. Temporal Transcriptome Analysis of SARS-CoV-2-Infected Lung and Spleen in Human ACE2-Transgenic Mice. Mol Cells 2022;45:896-910. [PMID: 36324270 DOI: 10.14348/molcells.2022.0089] [Reference Citation Analysis]
12 Jansen-Olliges L, Chatterjee S, Jia L, Stahl F, Bär C, Stadler M, Surup F, Zeilinger C. Multiformin-Type Azaphilones Prevent SARS-CoV-2 Binding to ACE2 Receptor. Cells 2022;12. [PMID: 36611877 DOI: 10.3390/cells12010083] [Reference Citation Analysis]
13 Rosada T, Napiórkowska-Baran K, Cała Ł, Alska E, Paulina K, Czarnowska M, Bartuzi Z. Safety of mRNA COVID-19 vaccinations in patients with allergic diseases. Public Health Pract (Oxf) 2023;5:100354. [PMID: 36590876 DOI: 10.1016/j.puhip.2022.100354] [Reference Citation Analysis]
14 Boguslavsky DV, Sharova NP, Sharov KS. Evolutionary Challenges to Humanity Caused by Uncontrolled Carbon Emissions: The Stockholm Paradigm. Int J Environ Res Public Health 2022;19. [PMID: 36554799 DOI: 10.3390/ijerph192416920] [Reference Citation Analysis]
15 Leena Hussein Bajrai, Sherif Ali El-Kafrawy, Ahmed Mohamed Hassan, Ahmed Majdi Tolah, Rabie Saleh Alnahas, Sayed Sartaj Sohrab, Mohd Rehan, Esam Ibraheem Azhar. In vitro screening of anti-viral and virucidal effects against SARS-CoV-2 by Hypericum perforatum and Echinacea. Sci Rep 2022;12:21723. [PMID: 36522420 DOI: 10.1038/s41598-022-26157-3] [Reference Citation Analysis]
16 Elkurwi N, Elkurwi Q. The Pathophysiological Relationship Between Migraine and SARS-CoV-2 Infection: A Comprehensive Literature Review. EMJ 2022. [DOI: 10.33590/emj/10054250] [Reference Citation Analysis]
17 Gdoura M, Halouani H, Sahli D, Mrad M, Chamsa W, Mabrouk M, Hogga N, Ben-Salem K, Triki H. SARS-CoV-2 Serology: Utility and Limits of Different Antigen-Based Tests through the Evaluation and the Comparison of Four Commercial Tests. Biomedicines 2022;10. [PMID: 36551862 DOI: 10.3390/biomedicines10123106] [Reference Citation Analysis]
18 Jovandaric MZ, Dokic M, Babovic IR, Milicevic S, Dotlic J, Milosevic B, Culjic M, Andric L, Dimic N, Mitrovic O, Beleslin A, Nikolic J, Jestrovic Z, Babic S. The Significance of COVID-19 Diseases in Lipid Metabolism Pregnancy Women and Newborns. Int J Mol Sci 2022;23. [PMID: 36499427 DOI: 10.3390/ijms232315098] [Reference Citation Analysis]
19 Ahmadi M, Alizadeh-navaei R, Haghshenas M, Mousavi T, Saeedi M, Hedayatizadeh-omran A, Valadan R. Differential gene expression of SARS-CoV-2 transcriptome provides insight into the design of more sensitive diagnostic tests. Human Gene 2022;34:201116. [DOI: 10.1016/j.humgen.2022.201116] [Reference Citation Analysis]
20 Maranduca MA, Vamesu CG, Tanase DM, Clim A, Drochioi IC, Pinzariu AC, Filip N, Dima N, Tudorancea I, Serban DN, Serban IL. The RAAS Axis and SARS-CoV-2: From Oral to Systemic Manifestations. Medicina (Kaunas) 2022;58. [PMID: 36556919 DOI: 10.3390/medicina58121717] [Reference Citation Analysis]
21 Morató JP, Pelegrí JL, Rey MM, Abelló AO, Vallès X, Roca J, de Liria CRG, Estrada O, Casanova IV. Environmental predictors of SARS-CoV-2 infection incidence in Catalonia (northwestern Mediterranean).. [DOI: 10.21203/rs.3.rs-2206639/v1] [Reference Citation Analysis]
22 Sano H, Imagawa A. Re-Enlightenment of Fulminant Type 1 Diabetes under the COVID-19 Pandemic. Biology 2022;11:1662. [DOI: 10.3390/biology11111662] [Reference Citation Analysis]
23 Leal D, Ferreira J, Mansilha A. Thromboembolic risk in pregnant women with SARS-CoV-2 infection - A systematic review. Taiwan J Obstet Gynecol 2022;61:941-50. [PMID: 36427996 DOI: 10.1016/j.tjog.2022.06.012] [Reference Citation Analysis]
24 Zhou C, Lin C, Hu Y, Zan H, Xu X, Sun C, Zou H, Li Y. Sensitive fluorescence biosensor for SARS-CoV-2 nucleocapsid protein detection in cold-chain food products based on DNA circuit and g-CNQDs@Zn-MOF. Lebensm Wiss Technol 2022;169:114032. [PMID: 36186577 DOI: 10.1016/j.lwt.2022.114032] [Reference Citation Analysis]
25 Robayo-Amortegui H, Forero-Delgadillo A, Pérez-Garzón M, Poveda-Henao C, Muñoz-Claros C, Bayona-Solano A, Orozco C, Buitrago-Bernal R. Severe gastrointestinal injury associated with SARS-CoV-2 infection: Thrombosis or Inflammation?: A retrospective case series study. Medicine (Baltimore) 2022;101:e31188. [PMID: 36281196 DOI: 10.1097/MD.0000000000031188] [Reference Citation Analysis]
26 Hao YJ, Wang YL, Wang MY, Zhou L, Shi JY, Cao JM, Wang DP. The origins of COVID-19 pandemic: A brief overview. Transbound Emerg Dis 2022. [PMID: 36218169 DOI: 10.1111/tbed.14732] [Reference Citation Analysis]
27 Jung S, Lee K. Atherosclerosis by Virus Infection—A Short Review. Biomedicines 2022;10:2634. [DOI: 10.3390/biomedicines10102634] [Reference Citation Analysis]
28 Fanelli M, Petrone V, Buonifacio M, Delibato E, Balestrieri E, Grelli S, Minutolo A, Matteucci C. Multidistrict Host–Pathogen Interaction during COVID-19 and the Development Post-Infection Chronic Inflammation. Pathogens 2022;11:1198. [DOI: 10.3390/pathogens11101198] [Reference Citation Analysis]
29 López Y, Muñoz-leal S, Martínez C, Guzmán C, Calderón A, Martínez J, Galeano K, Muñoz M, Ramírez JD, Faccini-martínez ÁA, Mattar S. Molecular evidence of Borrelia spp. in bats from Córdoba department, northwest Colombia.. [DOI: 10.21203/rs.3.rs-2114237/v1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Ur Rehman ME, Sabir B, Fazal F, Tanveer J, Haider T, Khalid AR, Saeed S, Basit J. Impact of COVID-19 restrictions on healthcare delivery for thalassemia major patients: A perspective from Pakistan. Annals of Medicine and Surgery 2022;82:104636. [DOI: 10.1016/j.amsu.2022.104636] [Reference Citation Analysis]
31 Choi YH. Post COVID-19 Emerging Infectious Diseases: What is the Next Pandemic Agent? Korean J Med 2022;97:277-283. [DOI: 10.3904/kjm.2022.97.5.277] [Reference Citation Analysis]
32 Chen Y, Zhao X, Zhou H, Zhu H, Jiang S, Wang P. Broadly neutralizing antibodies to SARS-CoV-2 and other human coronaviruses. Nat Rev Immunol 2022. [PMID: 36168054 DOI: 10.1038/s41577-022-00784-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Bennett M, Goodall E. Introduction. Autism and COVID-19 2022. [DOI: 10.1108/978-1-80455-033-520221001] [Reference Citation Analysis]
34 Zhang H, Liu J. Incorporating MOOC and COVID-19-Related Scientific Papers into Veterinary Microbiology Teaching to Enhance Students' Learning Performance and Professional Recognition. J Vet Med Educ 2022;:e20220036. [PMID: 36166201 DOI: 10.3138/jvme-2022-0036] [Reference Citation Analysis]
35 Zhang J, Gao Y, Wang X, Li N, Du X, Tang Y, Lai Q, Chen P, Yue C, Wu J, Kang K, Zhao M. Lymphocyte–C-reactive protein ratio can differentiate disease severity of COVID-19 patients and serve as an assistant screening tool for hospital and ICU admission. Front Immunol 2022;13:957407. [DOI: 10.3389/fimmu.2022.957407] [Reference Citation Analysis]
36 Cortés-Sarabia K, Luna-Pineda VM, Rodríguez-Ruiz HA, Leyva-Vázquez MA, Hernández-Sotelo D, Beltrán-Anaya FO, Vences-Velázquez A, Del Moral-Hernández O, Illades-Aguiar B. Utility of in silico-identified-peptides in spike-S1 domain and nucleocapsid of SARS-CoV-2 for antibody detection in COVID-19 patients and antibody production. Sci Rep 2022;12:15057. [PMID: 36064951 DOI: 10.1038/s41598-022-18517-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
37 Castrejón-jiménez NS, García-pérez BE, Reyes-rodríguez NE, Vega-sánchez V, Martínez-juárez VM, Hernández-gonzález JC. Challenges in the Detection of SARS-CoV-2: Evolution of the Lateral Flow Immunoassay as a Valuable Tool for Viral Diagnosis. Biosensors 2022;12:728. [DOI: 10.3390/bios12090728] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
38 Ayinde KS, Pinheiro GMS, Ramos CHI. Binding of SARS-CoV-2 protein ORF9b to mitochondrial translocase TOM70 prevents its interaction with chaperone HSP90. Biochimie 2022;200:99-106. [PMID: 35643212 DOI: 10.1016/j.biochi.2022.05.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
39 Wang M, Zhao Y, Liu J, Li T. SARS‐CoV‐2 modulation of RIG‐I‐MAVS signaling: Potential mechanisms of impairment on host antiviral immunity and therapeutic approaches. MedComm – Future Medicine 2022;1. [DOI: 10.1002/mef2.29] [Reference Citation Analysis]
40 Ćurčić M, Tarle M, Almahariq H, Hleb S, Havaš J, Pražetina M, Lasić H, Dolenc E, Kukoč A, Mihelčić A, Miko I, Romić A, Tipura D, Drmić Ž, Čučković M, Blagaj V, Lukšić I, Peršec J, Šribar A. Distribution of Pathogens and Predictive Values of Biomarkers of Inflammatory Response at ICU Admission on Outcomes of Critically Ill COVID-19 Patients with Bacterial Superinfections—Observations from National COVID-19 Hospital in Croatia. Diagnostics 2022;12:2069. [DOI: 10.3390/diagnostics12092069] [Reference Citation Analysis]
41 Tsermpini EE, Glamočlija U, Ulucan-Karnak F, Redenšek Trampuž S, Dolžan V. Molecular Mechanisms Related to Responses to Oxidative Stress and Antioxidative Therapies in COVID-19: A Systematic Review. Antioxidants (Basel) 2022;11:1609. [PMID: 36009328 DOI: 10.3390/antiox11081609] [Reference Citation Analysis]
42 Jainonthee C, Dang-xuan S, Nguyen-viet H, Unger F, Chaisowwong W. Impacts of the Pandemic, Animal Source Food Retailers’ and Consumers’ Knowledge and Attitudes toward COVID-19, and Their Food Safety Practices in Chiang Mai, Thailand. IJERPH 2022;19:10187. [DOI: 10.3390/ijerph191610187] [Reference Citation Analysis]
43 Debnath P, Khan U, Khan MS. Characterization and Structural Prediction of Proteins in SARS-CoV-2 Bangladeshi Variant Through Bioinformatics. Microbiol Insights 2022;15:11786361221115595. [PMID: 35966939 DOI: 10.1177/11786361221115595] [Reference Citation Analysis]
44 J. Tse T, Chicilo F, Popiel J, J.t. Reaney M. Implications of COVID-19 on Public Policy, Supply Chain Disruptions, and Monitoring Methods. Zoonoses of Public Health Interest [Working Title] 2022. [DOI: 10.5772/intechopen.105805] [Reference Citation Analysis]
45 Liu Q, Kwan KY, Cao T, Yan B, Ganesan K, Jia L, Zhang F, Lim C, Wu Y, Feng Y, Chen Z, Liu L, Chen J. Broad-spectrum antiviral activity of Spatholobus suberectus Dunn against SARS-CoV-2, SARS-CoV-1, H5N1, and other enveloped viruses. Phytother Res 2022;36:3232-47. [PMID: 35943221 DOI: 10.1002/ptr.7452] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Moskvicheva S, Novoseltsev S. Manual therapy capabilities for medical rehabilitation of post-COVID syndrome. Manual Therapy 2022;2022:37-48. [DOI: 10.54504/1684-6753-2022-2-37-48] [Reference Citation Analysis]
47 Edwards CE, Tata A, Baric RS. Human lung organoids as a model for respiratory virus replication and countermeasure performance in human hosts. Transl Res 2022:S1931-5244(22)00167-0. [PMID: 35850445 DOI: 10.1016/j.trsl.2022.07.002] [Reference Citation Analysis]
48 Huang XY, Yang LJ, Hu X, Zhang XX, Gu X, Du LJ, He ZY, Gu XJ. Elevated levels of fructosamine are independently associated with SARS-CoV-2 reinfection: A 12-mo follow-up study. World J Diabetes 2022; 13(7): 543-552 [DOI: 10.4239/wjd.v13.i7.543] [Reference Citation Analysis]
49 Mei Y, Lin X, He C, Zeng W, Luo Y, Liu C, Liu Z, Yang M, Kuang Y, Huang Q. Recent Progresses in Electrochemical DNA Biosensors for SARS-CoV-2 Detection. Front Bioeng Biotechnol 2022;10:952510. [DOI: 10.3389/fbioe.2022.952510] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Vivas Reyes R, Morales A, Márquez Lázaro J, Varela R, Herrera L, Vivas Gómez C. Acoplamiento molecular y modelado tridimensional por homología de flavonoides derivados de amentoflavona con las neuraminidasas H1N1 y H5N1 del virus de gripe aviar. Rev Colomb Quim 2022;50:32-41. [DOI: 10.15446/rev.colomb.quim.v50n3.97430] [Reference Citation Analysis]
51 Havasi A, Visan S, Cainap C, Cainap SS, Mihaila AA, Pop L. Influenza A, Influenza B, and SARS-CoV-2 Similarities and Differences – A Focus on Diagnosis. Front Microbiol 2022;13:908525. [DOI: 10.3389/fmicb.2022.908525] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Resta L, Vimercati A, Cazzato G, Fanelli M, Scarcella SV, Ingravallo G, Colagrande A, Sablone S, Stolfa M, Arezzo F, Lettini T, Rossi R. SARS-CoV-2, Placental Histopathology, Gravity of Infection and Immunopathology: Is There an Association? Viruses 2022;14:1330. [PMID: 35746801 DOI: 10.3390/v14061330] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Koch-heier J, Schönsiegel A, Waidele LM, Volk J, Füll Y, Wallasch C, Canisius S, Burnet M, Planz O. Pharmacokinetics, Pharmacodynamics and Antiviral Efficacy of the MEK Inhibitor Zapnometinib in Animal Models and in Humans. Front Pharmacol 2022;13:893635. [DOI: 10.3389/fphar.2022.893635] [Reference Citation Analysis]
54 Kiriacos CJ, Khedr MR, Tadros M, Youness RA. Prospective Medicinal Plants and Their Phytochemicals Shielding Autoimmune and Cancer Patients Against the SARS-CoV-2 Pandemic: A Special Focus on Matcha. Front Oncol 2022;12:837408. [PMID: 35664773 DOI: 10.3389/fonc.2022.837408] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 Alcendor DJ, Matthews-juarez P, Smoot D, Hildreth JEK, Lamar K, Tabatabai M, Wilus D, Juarez PD. Breakthrough COVID-19 Infections in the US: Implications for Prolonging the Pandemic. Vaccines 2022;10:755. [DOI: 10.3390/vaccines10050755] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
56 Jiménez D, Torres Arias M. Immunouniverse of SARS-CoV-2. Immunol Med 2022;:1-39. [PMID: 35502127 DOI: 10.1080/25785826.2022.2066251] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Choudhary P, Singh T, Amod A, Singh S. Evaluation of phytoconstituents of Tinospora cordifolia against K417N and N501Y mutant spike glycoprotein and main protease of SARS-CoV-2- an in silico study. J Biomol Struct Dyn 2022;:1-18. [PMID: 35467486 DOI: 10.1080/07391102.2022.2062787] [Reference Citation Analysis]
58 Dai J, Wang H, Liao Y, Tan L, Sun Y, Song C, Liu W, Qiu X, Ding C. Coronavirus Infection and Cholesterol Metabolism. Front Immunol 2022;13:791267. [DOI: 10.3389/fimmu.2022.791267] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
59 Wang H. COVID-19, Anti-NMDA Receptor Encephalitis and MicroRNA. Front Immunol 2022;13:825103. [PMID: 35392089 DOI: 10.3389/fimmu.2022.825103] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
60 I.m. P, A.a. S, A.e. S, E.a. M. FEATURES OF OBSERVATION OF PATIENTS IN AN ANTITUBERCULOUS HOSPITAL DURING THE PERIOD OF EPIDEMIC TROUBLE ACCORDING TO COVID-19. Mediko-farmacevtičeskij žurnal "Pulʹs" 2022. [DOI: 10.26787/nydha-2686-6838-2022-24-4-64-69] [Reference Citation Analysis]
61 Ralli M, Colizza A, D’aguanno V, Scarpa A, Russo G, Petrone P, Grassia R, Guarino P, Capasso P. Risk of SARS-CoV-2 contagion in otolaryngology specialists. Acta Otorhinolaryngol Ital 2022;42:S58-S67. [DOI: 10.14639/0392-100x-suppl.1-42-2022-06] [Reference Citation Analysis]
62 Ghazali SM, Singh S, Zulkifli AA, Cheong YL, Md Iderus NH, Md Zamri ASS, Ahmad Jaafar N, Lai CH, Wan Mohamed Noor WN, Rusli N, Chong CK, Aris T, Mohd Ibrahim H, Dass SC, Gill BS. COVID-19 in Malaysia: Descriptive Epidemiologic Characteristics of the First Wave. Int J Environ Res Public Health 2022;19:3828. [PMID: 35409511 DOI: 10.3390/ijerph19073828] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
63 Turecek PL, Hibbett D, Kreil TR. Plasma procurement and plasma product safety in light of the COVID-19 pandemic from the perspective of the plasma industry. Vox Sang 2022. [PMID: 35298841 DOI: 10.1111/vox.13267] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
64 Milenkovic M, Hadzibegovic A, Kovac M, Jovanovic B, Stanisavljevic J, Djikic M, Sijan D, Ladjevic N, Palibrk I, Djukanovic M, Velickovic J, Ratkovic S, Brajkovic M, Popadic V, Klasnja S, Toskovic B, Zdravkovic D, Crnokrak B, Markovic O, Bjekic-Macut J, Aleksic A, Petricevic S, Memon L, Milojevic A, Zdravkovic M. D-dimer, CRP, PCT, and IL-6 Levels at Admission to ICU Can Predict In-Hospital Mortality in Patients with COVID-19 Pneumonia. Oxid Med Cell Longev 2022;2022:8997709. [PMID: 35237386 DOI: 10.1155/2022/8997709] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
65 Kiremitler NB, Kemerli MZ, Kayaci N, Karagoz S, Pekdemir S, Sarp G, Sanduvac S, Onses MS, Yilmaz E. Nanostructures for the Prevention, Diagnosis, and Treatment of SARS-CoV-2: A Review. ACS Appl Nano Mater 2022;5:6029-54. [DOI: 10.1021/acsanm.2c00181] [Reference Citation Analysis]
66 Nappi F, Iervolino A, Avtaar Singh SS. Molecular Insights of SARS-CoV-2 Antivirals Administration: A Balance between Safety Profiles and Impact on Cardiovascular Phenotypes. Biomedicines 2022;10:437. [DOI: 10.3390/biomedicines10020437] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
67 Soszynska-jozwiak M, Ruszkowska A, Kierzek R, O’leary CA, Moss WN, Kierzek E. Secondary Structure of Subgenomic RNA M of SARS-CoV-2. Viruses 2022;14:322. [DOI: 10.3390/v14020322] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
68 Szarpak L, Mierzejewska M, Jurek J, Kochanowska A, Gasecka A, Truszewski Z, Pruc M, Blek N, Rafique Z, Filipiak KJ, Denegri A, Jaguszewski MJ. Effect of Coronary Artery Disease on COVID-19-Prognosis and Risk Assessment: A Systematic Review and Meta-Analysis. Biology (Basel) 2022;11:221. [PMID: 35205088 DOI: 10.3390/biology11020221] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
69 Xiong X, Tang N, Lai X, Zhang J, Wen W, Li X, Li A, Wu Y, Liu Z. Insights Into Amentoflavone: A Natural Multifunctional Biflavonoid. Front Pharmacol 2021;12:768708. [PMID: 35002708 DOI: 10.3389/fphar.2021.768708] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
70 Sayidmarie KH, Mohammed B, Mohammed AJ, Abbosh A. Combating Coronavirus Using Resonant Electromagnetic Irradiation. IEEE J Electromagn RF Microw Med Biol 2022. [DOI: 10.1109/jerm.2022.3194727] [Reference Citation Analysis]
71 Alshehri A, Hakami A. Seropositivity of COVID-19 asymptomatic nurses using Anti-SARS-CoV-2 nucleocapsid antibodies. King Khalid Univ J Health Sci 2022;7:91. [DOI: 10.4103/kkujhs.kkujhs_28_22] [Reference Citation Analysis]
72 Abrego-Martinez JC, Jafari M, Chergui S, Pavel C, Che D, Siaj M. Aptamer-based electrochemical biosensor for rapid detection of SARS-CoV-2: Nanoscale electrode-aptamer-SARS-CoV-2 imaging by photo-induced force microscopy. Biosens Bioelectron 2022;195:113595. [PMID: 34571481 DOI: 10.1016/j.bios.2021.113595] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 39.0] [Reference Citation Analysis]
73 Drożdżal S, Rosik J, Lechowicz K, Machaj F, Szostak B, Przybyciński J, Lorzadeh S, Kotfis K, Ghavami S, Łos MJ. An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment. Drug Resist Updat 2021;:100794. [PMID: 34991982 DOI: 10.1016/j.drup.2021.100794] [Cited by in Crossref: 48] [Cited by in F6Publishing: 63] [Article Influence: 24.0] [Reference Citation Analysis]
74 Rangaiah A, Shankar SM, Basawarajappa SG, Shah PA, Chandrashekar A, Munegowda A, Padukone S. Detection of SARS-CoV-2 in Clinical Samples: Target-specific Analysis of Qualitative Reverse Transcription–Polymerase Chain Reaction(RT-PCR) Diagnostic Kits. IJID Regions 2021;1:163-169. [DOI: 10.1016/j.ijregi.2021.11.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
75 Oktay L, Erdemoğlu E, Tolu İ, Yumak Y, Özcan A, Acar E, Büyükkiliç Ş, Olkan A, Durdaği S. Binary-QSAR guided virtual screening of FDA approved drugs and compounds in clinical investigation against SARS-CoV-2 main protease. Turk J Biol 2021;45:459-68. [PMID: 34803447 DOI: 10.3906/biy-2106-61] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
76 Qian Y, Lei T, Patel PS, Lee CH, Monaghan-Nichols P, Xin HB, Qiu J, Fu M. Direct Activation of Endothelial Cells by SARS-CoV-2 Nucleocapsid Protein Is Blocked by Simvastatin. J Virol 2021;95:e0139621. [PMID: 34549987 DOI: 10.1128/JVI.01396-21] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
77 Lin Y, Zang R, Ma Y, Wang Z, Li L, Ding S, Zhang R, Wei Z, Yang J, Wang X. Xanthohumol Is a Potent Pan-Inhibitor of Coronaviruses Targeting Main Protease. Int J Mol Sci 2021;22:12134. [PMID: 34830015 DOI: 10.3390/ijms222212134] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
78 Pinheiro T, Cardoso AR, Sousa CEA, Marques AC, Tavares APM, Matos AM, Cruz MT, Moreira FTC, Martins R, Fortunato E, Sales MGF. Paper-Based Biosensors for COVID-19: A Review of Innovative Tools for Controlling the Pandemic. ACS Omega 2021;6:29268-90. [PMID: 34778604 DOI: 10.1021/acsomega.1c04012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
79 Vitiello A, Ferrara F. A short focus, azithromycin in the treatment of respiratory viral infection COVID-19: efficacy or inefficacy? Immunol Res 2021. [PMID: 34739696 DOI: 10.1007/s12026-021-09244-x] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
80 Soszynska-jozwiak M, Kierzek R, Kierzek E. Secondary structure of subgenomic RNA M of SARS-CoV-2.. [DOI: 10.1101/2021.10.11.463917] [Reference Citation Analysis]
81 Peng YC, Cheng CH, Yatsuda H, Liu SH, Liu SJ, Kogai T, Kuo CY, Wang RYL. A Novel Rapid Test to Detect Anti-SARS-CoV-2 N Protein IgG Based on Shear Horizontal Surface Acoustic Wave (SH-SAW). Diagnostics (Basel) 2021;11:1838. [PMID: 34679536 DOI: 10.3390/diagnostics11101838] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
82 Violán C, Torán P, Quirant B, Lamonja-vicente N, Carrasco-ribelles LA, Chacón C, Manresa-dominguez JM, Ramos-roure F, Roso-llorach A, Pujol A, Ouchi D, Monteagudo M, Montero P, Garcia-sierra R, Arméstar F, Dacosta-aguayo R, Doladé M, Prat N, Bonet JM, Clotet B, Blanco I, Prado JG, Martínez Cáceres EM, for the ProHEpiC-19 Investigators. Antibody kinetics to SARS-CoV-2 at 13.5 months, by disease severity.. [DOI: 10.1101/2021.09.10.21262527] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
83 Di Micco S, Musella S, Sala M, Scala MC, Andrei G, Snoeck R, Bifulco G, Campiglia P, Fasano A. Peptide Derivatives of the Zonulin Inhibitor Larazotide (AT1001) as Potential Anti SARS-CoV-2: Molecular Modelling, Synthesis and Bioactivity Evaluation. Int J Mol Sci 2021;22:9427. [PMID: 34502335 DOI: 10.3390/ijms22179427] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
84 Rotondo JC, Martini F, Maritati M, Mazziotta C, Di Mauro G, Lanzillotti C, Barp N, Gallerani A, Tognon M, Contini C. SARS-CoV-2 Infection: New Molecular, Phylogenetic, and Pathogenetic Insights. Efficacy of Current Vaccines and the Potential Risk of Variants. Viruses 2021;13:1687. [PMID: 34578269 DOI: 10.3390/v13091687] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 18.5] [Reference Citation Analysis]
85 Desai A, Goretti G, Giordano M, Voza A. Lean-ing Method in an Emergency Department of the Italian Epicenter of the COVID-19 Outbreak: When the Algorithm Makes Difference. ASI 2021;4:55. [DOI: 10.3390/asi4030055] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
86 Gudowska-Sawczuk M, Mroczko B. The Role of Neuropilin-1 (NRP-1) in SARS-CoV-2 Infection: Review. J Clin Med 2021;10:2772. [PMID: 34202613 DOI: 10.3390/jcm10132772] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 9.5] [Reference Citation Analysis]
87 Lo Sasso B, Giglio RV, Vidali M, Scazzone C, Bivona G, Gambino CM, Ciaccio AM, Agnello L, Ciaccio M. Evaluation of Anti-SARS-Cov-2 S-RBD IgG Antibodies after COVID-19 mRNA BNT162b2 Vaccine. Diagnostics (Basel) 2021;11:1135. [PMID: 34206567 DOI: 10.3390/diagnostics11071135] [Cited by in Crossref: 41] [Cited by in F6Publishing: 47] [Article Influence: 20.5] [Reference Citation Analysis]
88 Singh H, Singh A, Khan AA, Gupta V. Immune mediating molecules and pathogenesis of COVID-19-associated neurological disease. Microb Pathog 2021;158:105023. [PMID: 34090983 DOI: 10.1016/j.micpath.2021.105023] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
89 Jelinek HF, Mousa M, Alefishat E, Osman W, Spence I, Bu D, Feng SF, Byrd J, Magni PA, Sahibzada S, Tay GK, Alsafar HS. Evolution, Ecology, and Zoonotic Transmission of Betacoronaviruses: A Review. Front Vet Sci 2021;8:644414. [PMID: 34095271 DOI: 10.3389/fvets.2021.644414] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
90 González-Candelas F, Shaw MA, Phan T, Kulkarni-Kale U, Paraskevis D, Luciani F, Kimura H, Sironi M. One year into the pandemic: Short-term evolution of SARS-CoV-2 and emergence of new lineages. Infect Genet Evol 2021;92:104869. [PMID: 33915216 DOI: 10.1016/j.meegid.2021.104869] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 17.5] [Reference Citation Analysis]
91 Resta L, Vimercati A, Cazzato G, Mazzia G, Cicinelli E, Colagrande A, Fanelli M, Scarcella SV, Ceci O, Rossi R. SARS-CoV-2 and Placenta: New Insights and Perspectives. Viruses 2021;13:723. [PMID: 33919284 DOI: 10.3390/v13050723] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 15.5] [Reference Citation Analysis]
92 Bharadwaj S, Dubey A, Yadava U, Mishra SK, Kang SG, Dwivedi VD. Exploration of natural compounds with anti-SARS-CoV-2 activity via inhibition of SARS-CoV-2 Mpro. Brief Bioinform 2021;22:1361-77. [PMID: 33406222 DOI: 10.1093/bib/bbaa382] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 23.0] [Reference Citation Analysis]
93 Altamimi AM, Obeid DA, Alaifan TA, Taha MT, Alhothali MT, Alzahrani FA, Albarrag AM. Assessment of 12 qualitative RT-PCR commercial kits for the detection of SARS-CoV-2. J Med Virol 2021;93:3219-26. [PMID: 33629747 DOI: 10.1002/jmv.26900] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
94 Qian Y, Lei T, Patel PS, Lee CH, Monaghan-Nichols P, Xin HB, Qiu J, Fu M. Direct activation of endothelial cells by SARS-CoV-2 nucleocapsid protein is blocked by Simvastatin. bioRxiv 2021:2021. [PMID: 33594363 DOI: 10.1101/2021.02.14.431174] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
95 Bharadwaj S, El-Kafrawy SA, Alandijany TA, Bajrai LH, Shah AA, Dubey A, Sahoo AK, Yadava U, Kamal MA, Azhar EI, Kang SG, Dwivedi VD. Structure-Based Identification of Natural Products as SARS-CoV-2 Mpro Antagonist from Echinacea angustifolia Using Computational Approaches. Viruses 2021;13:305. [PMID: 33672054 DOI: 10.3390/v13020305] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
96 Bajrai LH, El-kafrawy SA, Alnahas RS, Azhar EI. In vitro screening of anti-viral and virucidal effects against SARS-CoV-2 by Hypericum perforatum and Echinacea.. [DOI: 10.1101/2021.01.11.426295] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
97 Bharadwaj S, Singh M, Kirtipal N, Kang SG. SARS-CoV-2 and Glutamine: SARS-CoV-2 Triggered Pathogenesis via Metabolic Reprograming of Glutamine in Host Cells. Front Mol Biosci 2020;7:627842. [PMID: 33585567 DOI: 10.3389/fmolb.2020.627842] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 9.5] [Reference Citation Analysis]
98 Jeyavijayan S, Ramuthai M, Murugan P. Investigating Potential Part of α-Santonin in the Treatment of SARS-CoV-2 and Cervical Cancer based on Molecular Docking Strategy. Asian J Chem 2021;33:2313-2320. [DOI: 10.14233/ajchem.2021.23308] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
99 Bharadwaj S, Dwivedi VD, Kang SG, Kirtipal N, Sobti RC. Insights Into the Role of Angiotensin-Converting Enzyme 2 in the Onset of Severe Acute Respiratory Syndrome Coronavirus 2 Pathogenesis. Delineating Health and Health System: Mechanistic Insights into Covid 19 Complications 2021. [DOI: 10.1007/978-981-16-5105-2_13] [Reference Citation Analysis]
100 He W, Chen Q. [Progress in source tracking of SARS-CoV-2]. Nan Fang Yi Ke Da Xue Xue Bao 2020;40:1838-42. [PMID: 33380405 DOI: 10.12122/j.issn.1673-4254.2020.12.22] [Reference Citation Analysis]
101 Tirnakli U, Tsallis C. Epidemiological Model With Anomalous Kinetics: Early Stages of the COVID-19 Pandemic. Front Phys 2020;8:613168. [DOI: 10.3389/fphy.2020.613168] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
102 Bharadwaj S, Azhar EI, Kamal MA, Bajrai LH, Dubey A, Jha K, Yadava U, Kang SG, Dwivedi VD. SARS-CoV-2 Mpro inhibitors: identification of anti-SARS-CoV-2 Mpro compounds from FDA approved drugs. J Biomol Struct Dyn 2020;:1-16. [PMID: 33150855 DOI: 10.1080/07391102.2020.1842807] [Cited by in Crossref: 32] [Cited by in F6Publishing: 23] [Article Influence: 10.7] [Reference Citation Analysis]